133 related articles for article (PubMed ID: 23151824)
1. Nonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesothelioma.
Vogl TJ; Lindemayr S; Naguib NN; Gurung J; Nour-Eldin NE; Zangos S; Mbalisike EC
Radiology; 2013 Feb; 266(2):649-56. PubMed ID: 23151824
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Byrne MJ; Davidson JA; Musk AW; Dewar J; van Hazel G; Buck M; de Klerk NH; Robinson BW
J Clin Oncol; 1999 Jan; 17(1):25-30. PubMed ID: 10458214
[TBL] [Abstract][Full Text] [Related]
3. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S
Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099
[TBL] [Abstract][Full Text] [Related]
4. [Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages].
Vogl TJ; Zangos S; Heller M; Hammerstingl RM; Böcher E; Jacob U; Bauer RW
Rofo; 2007 Nov; 179(11):1181-8. PubMed ID: 17948195
[TBL] [Abstract][Full Text] [Related]
5. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Pinto C; Marino A; De Pangher Manzini V; Benedetti G; Galetta D; Mazzanti P; Del Conte G; dell'Amore D; Piana E; Giaquinta S; Lopez M; Martoni A
Lung Cancer; 2006 May; 52(2):199-206. PubMed ID: 16542747
[TBL] [Abstract][Full Text] [Related]
6. Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.
Karpathiou G; Argiana E; Koutsopoulos A; Froudarakis ME
Oncology; 2007; 73(5-6):426-9. PubMed ID: 18523361
[TBL] [Abstract][Full Text] [Related]
7. [Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence].
Vogl TJ; Heller M; Zangos S; Schwarz W; Eichler K; Mack MG; Berger D; Balzer JO
Rofo; 2003 May; 175(5):695-704. PubMed ID: 12743865
[TBL] [Abstract][Full Text] [Related]
8. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
9. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
Nowak AK; Byrne MJ; Williamson R; Ryan G; Segal A; Fielding D; Mitchell P; Musk AW; Robinson BW
Br J Cancer; 2002 Aug; 87(5):491-6. PubMed ID: 12189542
[TBL] [Abstract][Full Text] [Related]
10. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM; Baas P; Manegold Ch; Schouwink JH; Burgers JA; de Bruin HG; Mooi WJ; van Klaveren RJ; de Jonge MJ; van Meerbeeck JP
Br J Cancer; 2002 Feb; 86(3):342-5. PubMed ID: 11875695
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.
Kovac V; Zwitter M; Rajer M; Marin A; Debeljak A; Smrdel U; Vrankar M
Anticancer Drugs; 2012 Feb; 23(2):230-8. PubMed ID: 22027538
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.
Portalone L; Antilli A; Nunziati F; Crispino C; de Marinis F; Friggeri L; Lombardi A; Lorusso V; Pronzato P; Sambiasi D; Signora M;
Tumori; 2005; 91(1):15-8. PubMed ID: 15849999
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Kalmadi SR; Rankin C; Kraut MJ; Jacobs AD; Petrylak DP; Adelstein DJ; Keohan ML; Taub RN; Borden EC
Lung Cancer; 2008 May; 60(2):259-63. PubMed ID: 18006112
[TBL] [Abstract][Full Text] [Related]
14. Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma.
de Lima VA; Sørensen JB
Med Oncol; 2015 Feb; 32(2):458. PubMed ID: 25572813
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.
Vogl TJ; Naguib NN; Nour-Eldin NE; Bechstein WO; Zeuzem S; Trojan J; Gruber-Rouh T
Int J Cancer; 2012 Aug; 131(3):733-40. PubMed ID: 21976289
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.
Tourkantonis I; Makrilia N; Ralli M; Alamara C; Nikolaidis I; Tsimpoukis S; Charpidou A; Kotanidou A; Syrigos K
Am J Clin Oncol; 2011 Feb; 34(1):38-42. PubMed ID: 20142722
[TBL] [Abstract][Full Text] [Related]
19. Survival of mesothelioma in a palliative medical care unit in egypt.
Ibrahim N; Abou-Elela E; Darwish D
Asian Pac J Cancer Prev; 2013; 14(2):739-42. PubMed ID: 23621229
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
Castagneto B; Zai S; Dongiovanni D; Muzio A; Bretti S; Numico G; Botta M; Sinaccio G
Am J Clin Oncol; 2005 Jun; 28(3):223-6. PubMed ID: 15923792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
